Hemispherx Biopharma, Inc., HEB, Hit 2.02 and Up 2.02%
Hemispherx Biopharma, Inc.
Rochester, NY 8/31/2009 08:21 AM GMT (TransWorldNews)
Hemispherx Biopharma, Inc, a biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders, hit 2.02 and gained shares 2.02% higher.
The company opened with 2.00 with a daily range support from 1.94 - 2.11.
Last Trade: 2.02
Day's Range: 1.94 - 2.11
52wk Range: 0.25 - 4.5
Change: Up 0.04 (2.02%)
Volume: 6.71M
Avg Vol (3m): 7.04M
About The Capital Gains Report
The Capital Gains Report uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Please visit our site to join our free newsletter.Disclaimer: Full disclaimer at http://TheCapitalGainsReport.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither The Capital Gaions Report, nor any of its affiliates are registered investment advisor or broker dealers.
info@thecapitalgainsreport.com
www.thecapitalgainsreport.com
